Clinical studies based H3N2V influenza vaccine under newly awarded vaccine preparedness and response contract under HHSO100201200014I

Ended Awarded Last action

Contract number
HHSO10033003T
Awardee
Awarding agency
Obligated
$565,800

Award facts

Opportunity
Contract value 100% obligated
$565,800.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Emeryville, CA 94608, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $565,800

Quick answers

Who was awarded contract HHSO10033003T?

HHSO10033003T was awarded to Novartis Vaccines And Diagnostics, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 27, 2012.

How much is contract HHSO10033003T worth?

The government has obligated $565,800 on HHSO10033003T.

Is contract HHSO10033003T an order under another contract?

Yes. HHSO10033003T is a delivery order under HHSO100201200014I, an indefinite delivery contract, on Pandemic Influenza Preparedness and Response 2012-2016.

Was contract HHSO10033003T competed?

The extent of competition for HHSO10033003T was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login